Hishan Tharmaseelan

8PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 21, 2026
BrECADD in three days: Implementation of a condensed intensive first-line regimen in Hodgkin lymphoma.

|Jul 17, 2026
Prognostic impact of presentation phenotypes in early-stage favorable Hodgkin lymphoma.

|Jul 17, 2025
Positron Emission Tomography-Guided Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma: A Prospective, Multicenter, Single-Arm, Phase II Cohort of the German Hodgkin Study Group HD21 Trial.

Justin Ferdinandus, Helen Kaul, Alexander Fosså

|Jul 11, 2025
Sequential BCMA CAR T-cell therapy in refractory multiple myeloma.

Tim Richardson, Udo Holtick, Jan-Hendrik Frenking

Pageof 2

Frequent Collaborators

5 joint publications

Dennis A Eichenauer

4 joint publications

Paul Jan Bröckelmann

4 joint publications

Justin Ferdinandus

4 joint publications

Bastian von Tresckow